leader-EngmannC.jpg

Cyril Engmann, MD, FAAP, FAPS

Senior Director - Quality and Program Impact, and Institutional Official

Cyril Engmann, MD, FAAP, FAPS, is the Senior Director of Quality and Program Impact and Institutional Official at PATH, an international nonprofit health organization driving transformative innovation to save lives in more than 70 countries.

He is the senior leader accountable for providing deep scientific, medical, and public health expertise, operational excellence, oversight, and leadership across all divisions of the organization. He also oversees PATH’s research and regulatory affairs. Before this, Dr. Engmann served as Director of the Maternal, Newborn, Child Health, and Nutrition global program at PATH, leading a department of 140 staff working across five continents with a pipeline totaling $300 million. He is also a practicing neonatologist and Professor of Pediatrics and Public Health at the University of Washington Schools of Medicine and Public Health.

Before PATH, Dr. Engmann led the Bill & Melinda Gates Foundation Newborn Health Strategy, where he designed and oversaw a portfolio of grants totaling $200 million.

Dr. Engmann has extensive experience in the research, policy, program, advocacy, and strategic health leadership spheres, and he has led, shaped, or played leadership roles in numerous global initiatives, including the Every Newborn Action Plan, Nurturing Care for Early Childhood Development Framework, Global Preterm Research Consortium, and Maternal Immunization Network. Internationally, he is the Board Chair of the 20-year, $271 million Child Health and Mortality Prevention Surveillance (CHAMPS) research project and serves on the Steering Committees for the World Economic Forum, the Swiss National Science Foundation, and the Adara Group. He is also a Lancet Commissioner.

Nationally, Dr. Engmann sits on the Expert Panel that advises on all US-government-sponsored COVID-19 trials, and he is frequently invited to hold briefings at the US Congress on domestic and international health challenges and solutions. Within Washington State, he serves on the Governor of Seattle’s Principal Advisors Team for Challenge Seattle—an alliance of chief executive officers from 21 of the region’s largest employers, and on the Washington Research Foundation postdoctoral fellowship program.

Dr. Engmann has authored over 130 peer-reviewed publications and book chapters, white papers, and abstracts. He is board certified in Pediatrics and Neonatology and is a Fellow of the American Academy of Pediatrics, the Society for Pediatric Research, and the American Pediatric Society—an honor reserved for individuals who have distinguished themselves as child health leaders, teachers, scholars, policymakers, and clinicians and whose important contributions are recognized nationally and internationally.

Dr. Engmann has dedicated his life to combating social injustice and health inequity, and he is passionate about driving organizational impact through strategic, interdisciplinary, purpose-driven partnerships. Over his career, he has led or been part of multidisciplinary teams to receive over $800 million dollars in research and program funding. He is strongly committed to using data evidence to improve the human condition and put bold solutions into action.